Dr. Bataller completed a PhD from 1995-2000 on the pathogenesis of liver fibrosis. Between 2000 and 2003, he did postdoctoral research with David Brenner at UNC.  From 2004-2011 he directed the "Laboratory of Liver Fibrosis" at IDIBAPS, a research center associated with the Hospital Clinic in Barcelona where he also worked to develop new therapies for alcoholic liver disease and performed translational investigations on human samples to identify molecular determinants of alcoholic hepatitis. Dr. Bataller’s research is focused on the molecular mechanisms of steatohepatitis in order to identify new targets for therapy.